Posts

Showing posts with the label Acute Gout market outlook

Acute Gout – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Acute gout attacks manifest swiftly, reaching peak joint pain within 24 hours. Remission usually begins within 5 to 12 days without intervention, but complete resolution may take longer. Most attacks are monoarticular, with the first metatarsophalangeal joint being the initial site in approximately 50% of cases. While the pain typically peaks within 24 hours, chronic or variable intensity pain is more prevalent in patients with long-standing disease. Gout treatment involves addressing the pain and inflammation of acute attacks and long-term management focused on lowering serum urate levels. Gout patients, often older with multiple comorbidities, face challenges due to accompanying health conditions like diabetes and cardiovascular disease. Diagnosing gout relies on clinical signs, including sudden pain onset, past arthritis attacks, first MTP involvement, and elevated serum urate. However, not all criteria must be present. The ACR recommends pharmacologic therapy as the primary...